ChemicalBook > CAS DataBase List > Coltuximab Ravtansine
Coltuximab Ravtansine
- Product Name
- Coltuximab Ravtansine
- CAS No.
- 1269764-99-9
- Chemical Name
- Coltuximab Ravtansine
- Synonyms
- Coltuximab;Coltuximab Ravtansine;Coltuximab (anti-CD19);Research Grade Coltuximab
- CBNumber
- CB48080901
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Coltuximab Ravtansine Chemical Properties,Usage,Production
Uses
Coltuximab is a CHO-expressed humanized antibody that targets CD19. Coltuximab is composed of huIgG1 heavy chains and huκ light chains, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Coltuximab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
Coltuximab Ravtansine Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Coltuximab Ravtansine Suppliers
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
- Tel
- 15817493340
- 981810490@qq.com
- Country
- China
- ProdList
- 1566
- Advantage
- 58
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
- Country
- China
- ProdList
- 6762
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Country
- China
- ProdList
- 11973
- Advantage
- 58
- Tel
- 0731-13823398 15111215862
- 313359644@qq.com
- Country
- China
- ProdList
- 4161
- Advantage
- 58
- Tel
- 17316404525 17316404525
- 209533805@qq.com
- Country
- China
- ProdList
- 9763
- Advantage
- 58
1269764-99-9, Coltuximab RavtansineRelated Search:
dinutuximab
Frunevetmab
Ivonescimab
Zalifrelimab
Firivumab
Envafolimab
Nebacumab
Setoxaximab
Oxelumab
Ralpancizumab